Salcedo Mauricio, Pina-Sanchez Patricia, Vallejo-Ruiz Veronica, Monroy-Garcia Alberto, Aguilar-Lemarroy Adriana, Cortes-Gutierrez Elva I, Santos-Lopez Gerardo, Montoya-Fuentes Hector, Grijalva Renan, Madrid-Marina Vicente, Apresa-Garcia Teresa, Hernandez Dulce M, Jave-Suarez Luis F, Romero Pablo, Poot Albros, Salgado Eduardo, Ramos-Gonzalez Patricia, Gonzalez-Hernandez Rigoberto, Canton Juan C, Jimenez-Aranda Lucio, Parra-Melquiadez Miriam, Paniagua Lucero, Mendoza Monica, Arreola Hugo, Villegas Vanesa, Torres-Poveda Kirvis, Bahena-Roman Margarita, Gonzalez-Yebra Beatriz, Taniguchi Keiko, Rodea Carlos, Mantilla-Morales Alejandra, Mora-Garcia Maria L, Velazquez-Velazquez Cindy K, Cordova-Uscanga Candelaria, Peralta Raul, Lopez-Romero Ricardo, Marrero Daniel, Bandala Cindy, Reyes-Leyva Julio, Furuya Maria E, Almeida Eduardo, Galvan Maria E, Grijalva Israel
Unidad de Investigacion Medica en Enfermedades Oncologicas, Hospital de Oncologia, Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (Mexican Institute for Social Security; IMSS), Mexico E-mail :
Asian Pac J Cancer Prev. 2014;15(23):10061-6. doi: 10.7314/apjcp.2014.15.23.10061.
The aetiological relationship between human papillomavirus (HPV) infection and cervical cancer (CC) is widely accepted. Our goal was to determine the prevalence of HPV types in Mexican women attending at the Mexican Institute for Social Security from different areas of Mexico.
DNAs from 2,956 cervical samples were subjected to HPV genotyping: 1,020 samples with normal cytology, 931 with low-grade squamous intraepithelial lesions (LGSIL), 481 with high grade HGSIL and 524 CC.
Overall HPV prevalence was 67.1%. A total of 40 HPV types were found; HPV16 was detected in 39.4% of the HPV-positive samples followed by HPV18 at 7.5%, HPV31 at 7.1%, HPV59 at 4.9%, and HPV58 at 3.2%. HPV16 presented the highest prevalence both in women with altered or normal cytology and HPV 18 presented a minor prevalence as reported worldwide. The prevalence ratio (PR) was calculated for the HPV types. The analysis of PR showed that HPV16 presents the highest association with CC, HPV 31, -33, -45, -52 and -58 also demonstrating a high association.
The most prevalent HPV types in cervical cancer samples were -16, -18, -31, but it is important to note that we obtained a minor prevalence of HPV18 as reported worldwide, and that HPV58 and -52 also were genotypes with an important prevalence in CC samples. Determination of HPV genotypes is very important in order to evaluate the impact of vaccine introduction and future cervical cancer prevention strategies.
人乳头瘤病毒(HPV)感染与宫颈癌(CC)之间的病因学关系已被广泛认可。我们的目标是确定来自墨西哥不同地区、在墨西哥社会保障机构就诊的女性中HPV各型别的流行情况。
对2956份宫颈样本的DNA进行HPV基因分型:1020份样本细胞学正常,931份样本为低级别鳞状上皮内病变(LGSIL),481份样本为高级别鳞状上皮内病变(HGSIL),524份样本为宫颈癌。
HPV总体流行率为67.1%。共发现40种HPV型别;在HPV阳性样本中,HPV16的检出率为39.4%,其次是HPV18,为7.5%,HPV31为7.1%,HPV59为4.9%,HPV58为3.2%。HPV16在细胞学异常或正常的女性中均呈现最高流行率,而HPV18的流行率低于全球报告水平。计算了各HPV型别的流行率比值(PR)。PR分析表明,HPV16与宫颈癌的关联性最高,HPV 31、-33、-45、-52和-58也显示出高度关联性。
宫颈癌样本中最常见的HPV型别为-16、-18、-31,但需要注意的是,我们获得的HPV18流行率低于全球报告水平,并且HPV58和-52在宫颈癌样本中也是重要的流行基因型。确定HPV基因型对于评估疫苗引入的影响和未来宫颈癌预防策略非常重要。